{
  "symbol": "KNSA",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap company", "focus on unmet medical needs"],
    "riskScore": 7,
    "reason": "Kiniksa Pharmaceuticals operates in the biotech sector, which is prone to speculation, and is a small-cap company focusing on unmet medical needs, making it susceptible to retail-driven price movements."
  }
}